These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15388115)

  • 1. Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease.
    Schmaljohann J; Minnerop M; Karwath P; Gündisch D; Falkai P; Guhlke S; Wüllner U
    Appl Radiat Isot; 2004 Dec; 61(6):1235-40. PubMed ID: 15388115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease.
    Schmaljohann J; Gündisch D; Minnerop M; Bucerius J; Joe A; Reinhardt M; Guhlke S; Biersack HJ; Wüllner U
    Nucl Med Biol; 2006 Apr; 33(3):305-9. PubMed ID: 16631078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
    Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
    J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine).
    Pichika R; Easwaramoorthy B; Christian BT; Shi B; Narayanan TK; Collins D; Mukherjee J
    Nucl Med Biol; 2011 Nov; 38(8):1183-92. PubMed ID: 21831652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
    Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
    J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors--in vitro binding properties and PET studies in baboons.
    Valette H; Xiao Y; Peyronneau MA; Damont A; Kozikowski AP; Wei ZL; Kassiou M; Kellar KJ; Dollé F; Bottlaender M
    J Nucl Med; 2009 Aug; 50(8):1349-55. PubMed ID: 19652217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for alpha4beta2* nicotinic acetylcholine receptors.
    Gündisch D; Koren AO; Horti AG; Pavlova OA; Kimes AS; Mukhin AG; London ED
    Synapse; 2005 Feb; 55(2):89-97. PubMed ID: 15529332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use.
    Schmaljohann J; Gündisch D; Minnerop M; Joe A; Bucerius J; Dittmar C; Jessen F; Guhlke S; Wüllner U
    Appl Radiat Isot; 2005 Oct; 63(4):433-5. PubMed ID: 16024252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the nicotinic ligand 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo.
    Valette H; Bottlaender M; Dollé F; Guenther I; Coulon C; Hinnen F; Fuseau C; Ottaviani M; Crouzel C
    Life Sci; 1999; 64(5):PL93-7. PubMed ID: 10072197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo.
    Bucerius J; Manka C; Schmaljohann J; Mani V; Gündisch D; Rudd JH; Bippus R; Mottaghy FM; Wüllner U; Fayad ZA; Biersack HJ
    JACC Cardiovasc Imaging; 2012 May; 5(5):528-36. PubMed ID: 22595161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.
    Mitkovski S; Villemagne VL; Novakovic KE; O'Keefe G; Tochon-Danguy H; Mulligan RS; Dickinson KL; Saunder T; Gregoire MC; Bottlaender M; Dolle F; Rowe CC
    Nucl Med Biol; 2005 Aug; 32(6):585-91. PubMed ID: 16026705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic alpha4beta2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate.
    Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    Nucl Med Biol; 2006 Apr; 33(3):295-304. PubMed ID: 16631077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors.
    Iida Y; Ogawa M; Ueda M; Tominaga A; Kawashima H; Magata Y; Nishiyama S; Tsukada H; Mukai T; Saji H
    J Nucl Med; 2004 May; 45(5):878-84. PubMed ID: 15136639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiography of 2-[18F]F-A-85380 on nicotinic acetylcholine receptors in the porcine brain in vitro.
    Deuther-Conrad W; Wevers A; Becker G; Schildan A; Patt M; Sabri O; Steinbach J; Brust P
    Synapse; 2006 Mar; 59(4):201-10. PubMed ID: 16385508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: in vitro and in vivo evaluation.
    Chefer SI; Pavlova OA; Zhang Y; Vaupel DB; Kimes AS; Horti AG; Stein E; Mukhin AG
    J Neurochem; 2008 Jan; 104(2):306-15. PubMed ID: 17986233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.
    Saji H; Ogawa M; Ueda M; Iida Y; Magata Y; Tominaga A; Kawashima H; Kitamura Y; Nakagawa M; Kiyono Y; Mukai T
    Ann Nucl Med; 2002 May; 16(3):189-200. PubMed ID: 12126044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
    Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
    J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380.
    Valette H; Bottlaender M; Dollé F; Guenther I; Fuseau C; Coulon C; Ottaviani M; Crouzel C
    J Nucl Med; 1999 Aug; 40(8):1374-80. PubMed ID: 10450691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo measurement of nicotinic acetylcholine receptors with [18F]norchloro-fluoro-homoepibatidine.
    Brust P; Patt JT; Deuther-Conrad W; Becker G; Patt M; Schildan A; Sorger D; Kendziorra K; Meyer P; Steinbach J; Sabri O
    Synapse; 2008 Mar; 62(3):205-18. PubMed ID: 18088060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.